Health Archive » November, 2006

Health - November, 2006

131 articles

• Court Brings Suit Against Blue Cross Back To Life
• Scrushy Settles Claims Over Bonuses, Legal Fees
• Eli Lilly & Co. Sued By 105 Plaintiffs Over Zyprexa
• Miami Hospital Settles Kickback Charges For $15.4M
• Saint Vincent Wants To Sell Unpaid Patient Claims
• Drug-Coated Stents Face Further Scrutiny
• Appeals Court Lets Biotech Patent Suit Proceed
• Merck Downplayed Vioxx Risks, Doctor Testifies
• Trial Starts In Pfizer's Norvasc Patent Dispute
• UnitedHealth Shareholders: Freeze McGuire Assets
• Court Refuses To Toss Claims Against Medtronic
• World Health To Settle Class Action For $2.7M
• Cytosol Accosts Chubb For Insurance Money
• Machine Companies Settle Patent Suit
• FDA Fines Red Cross For Blood-Safety Violations
• ITC To Review Smallpox Vaccine Ruling
• Hospital Sued For Sexual Harrassment, Retaliation
• Federal Circuit Denies Amgen's Rehearing Request
• Wyeth, Others Face New Hormone Replacement Suit
• Judge Rules Vioxx Claims Should Be Tried Separately
• Court Rejects J&J Bid For Injunction In Amgen Case
• Uninsured Patients' Class Action Gets Green Light
• Cancer Vaccine Co. Files For Chapter 7
• State Attorney General Probes Off-Label Actiq Use
• Tenet Healthcare Settles Most Of Tax Case With IRS
• Court Snubs Last-Ditch Motion In Univasc Suit
• Ruling Favors Scrushy In Probe Into Juror Behavior
• Whistleblowers Propel Government Fraud Recoveries
• Orthopedic Company Comes Under SEC Scrutiny
• Bush Nominee For Family Planning Continues To Rankle
• Teva To Pay Up To $70M To Settle With Pfizer
• FDA May Speed Drug Ad Review For Fee
• Judge Grants Class Status To Mentally Ill Plaintiffs
• New Cyberonics Chairman Probed For Backdating
• Federal Circuit Boosts Impax In Aventis Patent Suit
• The Massachusetts Health Care Reform Act's Health Insurance Nondiscrimination Rule
• Catheter Maker Settles Antitrust Suit
• Patients Cannot Sue Doctors Under HIPAA, Court Rules
• Another Republican Vows To Block FDA Confirmation
• Appeals Court Revives Patent Suit Over Spinal Screws
• Pfizer Hardens Stance Over Chinese Viagra
• Human Error or Criminal Conduct – How Can One Tell the Difference?
• Biovail CEO Tries To Muscle Back Into Bankruptcy Case
• Alcon Sues Apotex To Block Generic Eye Drug
• Saint Vincent Granted Extension Of Exclusive Rights
• Drinker Biddle To Gain Top Health Care Group In Merger
• Novo Nordisk Sues USPTO Over AERx Applications
• Inverness Patent Saga Ends In Multimillion-Dollar Pact
• Pharmaceutical Giants Face Wage And Hour Claims
• Interference Proceeding Ordered In DNA Tech Spat
• City Sues Kaiser For Dumping Patients On Streets
• New Rules Addressing Physician Payment And Outpatient Procedures On Public Display
• Federal Circuit Upholds Patent Ruling In Diprivan Case
• Solutia Supports Extension Bid
• Immune Response Settles Shareholder Suits
• Dusa Sues Chemical Co. Over Skin Treatment Patents
• Monsanto Fires Back At Solutia Noteholders
• Jury Gives Merck Another Vioxx Win
• Saint Vincent Seeks Extension of Ch. 11 Plan
• Generics Maker Settles Imitrex Suit With Glaxo
• Sales Rep Challenges Eli Lilly For Unpaid Overtime
• FDA Eyes Sanofi Antibiotic Over Safety Concerns
• Warner Chilcott Calls Truce Over Birth Control Drug
• Companies Settle Patent Suit Over Vascular Product
• Omnicare Settles Fraud Charges For $49.5M
• Medical Device Co. Pokes Bayer With Suit Over Lancets
• Synergetics Starts A Battle In Eye Surgery Patent War
• NYC's Bid To Halt Health Insurance Cos. Merger Denied
• U.S. Appeals Court Upholds Generic Zocor's Exclusivity
• San Francisco Trade Group Sues Over Health Care Law
• Data Exclusivity Rules Rile Canadian Generics Makers
• Can Nonprofit Hospitals Coexist With Physician Ownership?
• Stryker Wins Second Round In Bout With Acumed
• Shire Unit Asserts Adderall Patents Against Andrx
• SeraCare Agrees To Shareholder's Chapter 11 Plan
• Metabolife Forks Over $56M In Ephedra Settlement
• Spectrum Settles With Glaxo Over Imitrex
• Vioxx Class Action Approved In Quebec
• Jury Awards Blind Boy $20M In Negligence Case
• Former Yale Scientist Says She's Lost Out On Royalties
• Crowell Snags Health & Employment Boutique
• Court Scraps Counterclaims Against J&J Unit
• Judge Unmoved By Brockovich's Latest Campaign
• Hypertension Patients Join Feud Over Pfizer's Norvasc
• Democrats Take Control, Look To Reform Drug Laws
• FTC Probes Adderall Settlement Between Barr, Shire
• FDA To Up Postmarket Regulation Of Medical Devices
• Advocates Can Subpoena White House In Plan B Suit
• Hospital Co. Settles Shareholder Suits Over Merger
• Pharma Stalls U.S., Korean Free Trade Talks
• California Work-At-Home Employees Sue Cigna Healthcare
• Shareholders Rebel Against Connetics
• Aetna In Hot Water Over Anorexia Coverage
• Abbott's Ultane Patent Declared Invalid
• Jury Rejects Doctor's Claim Over Genentech Drug
• Claimants Push To Remove Saint Vincent's Stay
• Pfizer Attacked Over Lipitor Licensing Pact
• Merck Riled In Tax Dispute With U.S. And Canada
• Martha Stewart's Co. To Settle ImClone Suit For $30M
• Teva Motions Denied In Patent Spat With Pfizer
• Stryker CEO Says DOJ Should End Price-Fixing Probe
• Generic Allegra To Remain On The Market
• Bradley Pharmaceuticals Derivative Action Dismissed
• Judge To Consider If Jurors Broke Rules In Scrushy Case
• Jury Awards Mother $15M In Medical Negligence Case
• QLT Liable For Unfair Trade In Visudyne Litigation
• High Court Ask DOJ To Weigh In On Damages
• Appeals Court Grants EEOC Win Against Nursing Home
• FDA Warns Bausch & Lomb After Plant Inspection
• Apotex' Antitrust Claims In Patent Case Approved
• McKesson Executives Dodge Conspiracy Bullet
• Baxter Healthcare Worker's Claims Tossed
• Health Labor Lawyer Joins Epstein Becker & Green
• CV Therapeutics Offers $13.5M In Settlement Agreement
• Antitrust Suit Claims Eisai Duped Patent Agency
• Pharmaceutical Giants, Consumers Spar As Trial Looms
• Court Denies J&J Unit's Motion In Spinal Screw Suit
• Eli Lilly Receives Subpoena Over Zyprexa
• Cyberonics Shareholder Pushes For Annual Meeting
• Israeli Researchers Want ImClone To Pay Royalties
• CVS-Caremark Merger Creates Antitrust Complications
• Ortho-McNeil Faces More Suits Over Contraceptive
• Warner Chilcott Hit With Suit Over IPO Prospectus
• Genentech Backtracks In Synagis Dispute
• Groups Spar Over Medical Assistant Certification
• Judge Trebles Invitrogen's Cash Award
• Supreme Court Denies Ferring B.V.'s Petition
• Amerigroup To Fight Back Against $144M Verdict
• As Prices Are Slashed, Drug Makers Eye German Law
• Glaxo Agrees To Settle Paxil Litigation For $63.8M
• Abortion Records Given To Kansas Attorney General